These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Evidence for in vivo growth potential and vascular remodeling of tissue-engineered artery. Cho SW; Kim IK; Kang JM; Song KW; Kim HS; Park CH; Yoo KJ; Kim BS Tissue Eng Part A; 2009 Apr; 15(4):901-12. PubMed ID: 18783324 [TBL] [Abstract][Full Text] [Related]
25. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model. Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821 [TBL] [Abstract][Full Text] [Related]
27. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression. Fukunishi T; Ong CS; He YJ; Inoue T; Zhang H; Steppan J; Matsushita H; Johnson J; Santhanam L; Hibino N Tissue Eng Part A; 2021 Nov; 27(21-22):1368-1375. PubMed ID: 33599167 [TBL] [Abstract][Full Text] [Related]
28. Considerations in the Development of Small-Diameter Vascular Graft as an Alternative for Bypass and Reconstructive Surgeries: A Review. Obiweluozor FO; Emechebe GA; Kim DW; Cho HJ; Park CH; Kim CS; Jeong IS Cardiovasc Eng Technol; 2020 Oct; 11(5):495-521. PubMed ID: 32812139 [TBL] [Abstract][Full Text] [Related]
29. Tissue-engineered blood vessels with endothelial nitric oxide synthase activity. Lim SH; Cho SW; Park JC; Jeon O; Lim JM; Kim SS; Kim BS J Biomed Mater Res B Appl Biomater; 2008 May; 85(2):537-46. PubMed ID: 18076094 [TBL] [Abstract][Full Text] [Related]
30. Tissue engineered vascular grafts: current state of the field. Ong CS; Zhou X; Huang CY; Fukunishi T; Zhang H; Hibino N Expert Rev Med Devices; 2017 May; 14(5):383-392. PubMed ID: 28447487 [TBL] [Abstract][Full Text] [Related]
31. Development and in vivo evaluation of small-diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(ε-caprolactone) nanofibrous scaffolds. Zhou M; Qiao W; Liu Z; Shang T; Qiao T; Mao C; Liu C Tissue Eng Part A; 2014 Jan; 20(1-2):79-91. PubMed ID: 23902162 [TBL] [Abstract][Full Text] [Related]
32. Hypoxia facilitates proliferation of smooth muscle cells derived from pluripotent stem cells for vascular tissue engineering. Fang L; Mei J; Yao B; Liu J; Liu P; Wang X; Zhou J; Lin Z J Tissue Eng Regen Med; 2022 Aug; 16(8):744-756. PubMed ID: 35633489 [TBL] [Abstract][Full Text] [Related]
33. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells. Zhao J; Liu L; Wei J; Ma D; Geng W; Yan X; Zhu J; Du H; Liu Y; Li L; Chen F Artif Organs; 2012 Jan; 36(1):93-101. PubMed ID: 21790675 [TBL] [Abstract][Full Text] [Related]
34. Magnetic Resonance Imaging of Shear Stress and Wall Thickness in Tissue-Engineered Vascular Grafts. Stacy MR; Best CA; Maxfield MW; Qiu M; Naito Y; Kurobe H; Mahler N; Rocco KA; Sinusas AJ; Shinoka T; Sampath S; Breuer CK Tissue Eng Part C Methods; 2018 Aug; 24(8):465-473. PubMed ID: 29978768 [TBL] [Abstract][Full Text] [Related]
37. Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis. Mirhaidari GJM; Barker JC; Zbinden JC; Santantonio BM; Chang YC; Best CA; Reinhardt JW; Blum KM; Yi T; Breuer CK Adv Healthc Mater; 2020 Dec; 9(24):e2001094. PubMed ID: 33073543 [TBL] [Abstract][Full Text] [Related]
38. Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. Dean EW; Udelsman B; Breuer CK Yale J Biol Med; 2012 Jun; 85(2):229-38. PubMed ID: 22737051 [TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered blood vessel graft produced by self-derived cells and allogenic acellular matrix: a functional performance and histologic study. Yang D; Guo T; Nie C; Morris SF Ann Plast Surg; 2009 Mar; 62(3):297-303. PubMed ID: 19240529 [TBL] [Abstract][Full Text] [Related]